Mount Yale Investment Advisors LLC Reduces Holdings in The Cigna Group (NYSE:CI)

Mount Yale Investment Advisors LLC lessened its holdings in The Cigna Group (NYSE:CI) by 7.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,608 shares of the health services provider’s stock after selling 128 shares during the period. Mount Yale Investment Advisors LLC’s holdings in The Cigna Group were worth $584,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Hanson & Doremus Investment Management lifted its stake in The Cigna Group by 3.5% during the 1st quarter. Hanson & Doremus Investment Management now owns 867 shares of the health services provider’s stock worth $315,000 after acquiring an additional 29 shares in the last quarter. Capital Asset Advisory Services LLC increased its position in shares of The Cigna Group by 2.3% during the first quarter. Capital Asset Advisory Services LLC now owns 1,280 shares of the health services provider’s stock worth $464,000 after acquiring an additional 29 shares during the period. Capital Advisors Ltd. LLC boosted its holdings in The Cigna Group by 10.6% in the first quarter. Capital Advisors Ltd. LLC now owns 335 shares of the health services provider’s stock valued at $122,000 after purchasing an additional 32 shares during the period. First Financial Corp IN increased its holdings in The Cigna Group by 17.2% during the 1st quarter. First Financial Corp IN now owns 225 shares of the health services provider’s stock worth $82,000 after purchasing an additional 33 shares during the period. Finally, Somerset Trust Co raised its position in The Cigna Group by 1.6% in the 1st quarter. Somerset Trust Co now owns 2,209 shares of the health services provider’s stock valued at $802,000 after purchasing an additional 34 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

The Cigna Group Price Performance

CI stock traded up $7.53 during trading on Tuesday, hitting $354.07. The stock had a trading volume of 155,205 shares, compared to its average volume of 1,550,180. The Cigna Group has a 1-year low of $253.95 and a 1-year high of $365.71. The company’s 50 day moving average price is $335.24 and its two-hundred day moving average price is $338.14. The stock has a market cap of $100.58 billion, a price-to-earnings ratio of 28.46, a price-to-earnings-growth ratio of 1.05 and a beta of 0.52. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.71 and a current ratio of 0.71.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.17 by $0.30. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The business had revenue of $57.25 billion for the quarter, compared to analysts’ expectations of $56.59 billion. During the same quarter last year, the firm earned $5.41 earnings per share. The business’s revenue was up 23.2% on a year-over-year basis. On average, sell-side analysts forecast that The Cigna Group will post 28.47 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 19th. Shareholders of record on Wednesday, September 4th will be issued a $1.40 dividend. The ex-dividend date is Wednesday, September 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.58%. The Cigna Group’s dividend payout ratio (DPR) is presently 45.98%.

Insider Buying and Selling

In other The Cigna Group news, Director Elder Granger sold 547 shares of the company’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $331.38, for a total transaction of $181,264.86. Following the completion of the sale, the director now directly owns 5,471 shares in the company, valued at $1,812,979.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other The Cigna Group news, insider Brian C. Evanko sold 4,795 shares of the company’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $345.01, for a total value of $1,654,322.95. Following the completion of the transaction, the insider now owns 39,923 shares in the company, valued at approximately $13,773,834.23. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Elder Granger sold 547 shares of the business’s stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the completion of the transaction, the director now owns 5,471 shares in the company, valued at approximately $1,812,979.98. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 22,988 shares of company stock valued at $7,975,726. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CI has been the topic of a number of recent research reports. Oppenheimer upped their target price on shares of The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a research note on Friday, May 3rd. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 20th. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a research note on Wednesday, July 10th. Baird R W raised The Cigna Group to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Robert W. Baird began coverage on The Cigna Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $388.00 price target on the stock. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, The Cigna Group currently has an average rating of “Buy” and a consensus target price of $376.20.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.